NTRA - ナテラ (Natera Inc.)

NTRAのニュース

   Natera and Genentech Initiate Phase III Trial Using Signatera™ as a Companion Diagnostic for Atezolizumab in Early-Stage Muscle-Invasive Bladder Cancer  2021/03/10 14:03:00 PR Newswire
AUSTIN, Texas, March 10, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the first patient has been screened in a new phase III clinical trial that uses its tumor-informed, personalized molecular residual disease…
   Preimplantation Genetic Diagnosis Market - Abbott Laboratories, Illumina, Inc., Natera Inc., PerkinElmer, Inc., F. Hoffman-La-Roche Ltd, Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Inc., Reproductive Gene  2021/03/08 06:32:40 OpenPR
Preimplantation Genetic Diagnosis Market Report 2020-2027 includes a comprehensive analysis of the present Market. The report starts with the basic Preimplantation Genetic Diagnosis industry overview and then goes into each and every detail. Preimplantation Genetic Diagnosis Market Report contains in depth
   Natera Reports Fourth Quarter and Year 2020 Financial Results  2021/02/25 21:05:00 PR Newswire
SAN CARLOS, Calif., Feb. 25, 2021 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today reported financial results for the fourth quarter and year ended December 31, 2020 and provided an update on recent business progress. Recent…
   Natera Announces Fourth Quarter and Fiscal 2020 Earnings Conference Call  2021/02/18 14:03:00 PR Newswire
SAN CARLOS, Calif., Feb. 18, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its fourth quarter and year ended December 31, 2020, after the market close on February 25, 2021. Natera…
   Natera and Personalis Partner for Personalized Monitoring in Oncology  2021/02/17 14:01:00 Business Wire
MENLO PARK, Calif. & SAN CARLOS, Calif.--(BUSINESS WIRE)---- $NTRA #PrecisionOncology--Natera and Personalis Partner for Personalized Monitoring in Oncology
   Natera Reports Fourth Quarter and Year 2020 Financial Results  2021/02/25 21:05:00 PR Newswire
SAN CARLOS, Calif., Feb. 25, 2021 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today reported financial results for the fourth quarter and year ended December 31, 2020 and provided an update on recent business progress. Recent…
   Natera Announces Fourth Quarter and Fiscal 2020 Earnings Conference Call  2021/02/18 14:03:00 PR Newswire
SAN CARLOS, Calif., Feb. 18, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its fourth quarter and year ended December 31, 2020, after the market close on February 25, 2021. Natera…
   Natera and Personalis Partner for Personalized Monitoring in Oncology  2021/02/17 14:01:00 Business Wire
MENLO PARK, Calif. & SAN CARLOS, Calif.--(BUSINESS WIRE)---- $NTRA #PrecisionOncology--Natera and Personalis Partner for Personalized Monitoring in Oncology
   Natera to Participate in Upcoming Investor Conferences  2021/02/11 14:03:00 PR Newswire
SAN CARLOS, Calif., Feb. 11, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that Alexey Aleshin, MD, Natera's Senior Medical Director of Oncology, will participate in a panel discussion at the BTIG Virtual MedTech,…
   Global Non-Invasive Prenatal Testing (NIPT) Market By Top Players: Sequenom, Roche (Ariosa Diagnostics); Natera, LabCorp, BGI Genomics; Quest Diagnostics, Illumina, Laboratory Corporation of America Holdings, Yourgene Health, and Berry Genomics.  2021/02/04 11:52:11 OpenPR
The report "Global Non-Invasive Prenatal Testing (NIPT) Market, By Product Type (Devices, Consumables, and Others), By Techniques (cfDNA, Biochemical Screening Tests, and Ultrasound Detection), By Application (Trisomy, Microdeletion syndrome, and Others), By End-User (Diagnostic Laboratories, Hospitals, and Cell DNA screening),
   Global Non-Invasive Prenatal Testing (NIPT) Market By Top Players: Sequenom, Roche (Ariosa Diagnostics); Natera, LabCorp, BGI Genomics; Quest Diagnostics, Illumina, Laboratory Corporation of America Holdings, Yourgene Health, and Berry Genomics.  2021/02/04 11:52:11 OpenPR
The report "Global Non-Invasive Prenatal Testing (NIPT) Market, By Product Type (Devices, Consumables, and Others), By Techniques (cfDNA, Biochemical Screening Tests, and Ultrasound Detection), By Application (Trisomy, Microdeletion syndrome, and Others), By End-User (Diagnostic Laboratories, Hospitals, and Cell DNA screening),
   Panorama® SMART Study Confirms Market-Leading Performance in Largest Prospective NIPT Trial to Date  2021/02/03 14:03:00 PR Newswire
SAN CARLOS, Calif., Feb. 3, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cfDNA testing, presented key results from its SMART study at the SMFM 41st Annual Pregnancy Meeting.1-3 The SMART study is the largest prospective, multi-site study ever performed…
   SMART Study Finds 22q11.2 Microdeletion Prevalence Much Higher than Expected  2021/02/01 14:03:00 PR Newswire
SAN CARLOS, Calif., Feb. 1, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cfDNA testing, presented key results from its SMART study at the SMFM 41st Annual Pregnancy Meeting.1 The SMART study sets a new standard as the largest prospective NIPT study to…
   Leerink Partners Stick to Their Buy Rating for Natera By Investing.com  2021/01/20 12:45:40 Investing.com
Leerink Partners Stick to Their Buy Rating for Natera
   Canaccord Genuity Stick to Their Buy Rating for Natera By Investing.com  2021/01/14 23:25:07 Investing.com
Canaccord Genuity Stick to Their Buy Rating for Natera

calendar